Corrigendum to ‘GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft’ [Canc. Lett. 330 (2013) 22–32]

MLA

Jay Sharma, et al. “Corrigendum to ‘GANT-61 Inhibits Pancreatic Cancer Stem Cell Growth in Vitro and in NOD/SCID/IL2R Gamma Null Mice Xenograft’ [Canc. Lett. 330 (2013) 22–32].” Cancer Letters, vol. 522, Dec. 2021, p. 282. EBSCOhost, https://doi.org/10.1016/j.canlet.2021.07.028.

APA

Jay Sharma, Sanjit K. Roy, Sharmila Shankar, Junsheng Fu, Mariana Rodova, Rakesh K. Srivastava, & Karan P. Singh. (2021). Corrigendum to ‘GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft’ [Canc. Lett. 330 (2013) 22–32]. Cancer Letters, 522, 282. https://doi.org/10.1016/j.canlet.2021.07.028

Chicago

Jay Sharma, Sanjit K. Roy, Sharmila Shankar, Junsheng Fu, Mariana Rodova, Rakesh K. Srivastava, and Karan P. Singh. 2021. “Corrigendum to ‘GANT-61 Inhibits Pancreatic Cancer Stem Cell Growth in Vitro and in NOD/SCID/IL2R Gamma Null Mice Xenograft’ [Canc. Lett. 330 (2013) 22–32].” Cancer Letters 522 (December): 282. doi:10.1016/j.canlet.2021.07.028.